Press Releases Current page: 2

Medical wearables and apps will be an essential part of telemedicine in the future. This offers new opportunities for established healthcare companies.

The use of IT and AI increases efficiency and quality of care in medicine – but also the vulnerability of the systems. How do we combine progress with security?

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care sector. Its business activities include […]

Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective.

For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff.

Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system.

ntv reported in an exciting TV report about Mental Health Apps with focus on the DiGa of the SHS portfolio company Selfapy GmbH. It shows that digital therapies are increasingly arriving in mainstream care. Especially in the pandemic, low-threshold digital solutions are a great added value for patients.

ESG, SRI, impact investing: when did this start, and what is its importance in the healthcare sector?

In a Podcast Caroline Sai of EIT Health and our Partner Andre Zimmermann are discussing in which ways the new MDR is heavily affecting the whole European Medtech area – from start-ups to established medium-sized companies. In addition, SHS is out-lining in which way medium-sized companies and investors can team-up not only to overcome the economical challenges of the MDR for Medtechs but to prosper.

Digitization is one of the major challenges facing the medtech industry. Those who want to master them need courage, know-how and capital.

‘Brexit is done’, as British Prime Minister Johnson wholeheartedly announced. But what does this mean for the SME-based healthcare and medtech sector? Read about it the current column by Dr. André Zimmermann.

The Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH invests from its SHS V fund in the Swiss-German specialty pharmaceuticals company Develco Pharma.